Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus

Journal of Virology

Volumn 79, Issue 8, 2005, Pages 4838-4847

  Bautista, Elida M ^a   Ferman, Geoffrey S ^a   Gregg, Douglas ^a   Brum, Mario C S ^a   Grubman, Marvin J ^a   Golde, William T ^a,b  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; BETA INTERFERON; CD86 ANTIGEN; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INFECTION RESISTANCE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; VIRUS INFECTION;

CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; INTERFERON-ALPHA; MICROSCOPY, CONFOCAL; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN;

EID: 16244372726     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.8.4838-4847.2005     Document Type: Article

References (64)

1. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732-738.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
3. Bautista, E. M., G. S. Ferman, and W. T. Golde. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 92:61-73.
4. Bautista, E. M., D. Gregg, and W. T. Golde. 2002. Characterization and functional analysis of skin-derived dendritic cells from swine without a requirement for in vitro propagation. Vet. Immunol. Immunopathol. 88:131-148.
5. Bautista, E. M., and T. W. Molitor. 1997. Cell-mediated immunity to porcine reproductive and respiratory syndrome virus in swine. Viral Immunol. 10:83-94.
6. 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664-2666.
7. Blomberg, S., M. L. Eloranta, B. Cederblad, K. Nordlin, G. V. Alm, and L. Ronnblom. 2001. Presence of cutaneous interferon-α producing cells in patients with systemic lupus erythematosus. Lupus 10:484-490.
8. Brown, C. C., M. E. Piccone, P. W. Mason, T. S. McKenna, and M. J. Grubman. 1996. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol. 70:5638-5641.
9. Callahan, J. D., F. Brown, F. A. Osorio, J. H. Sur, E. Kramer, G. W. Long, J. Lubroth, S. J. Ellis, K. S. Shoulars, K. L. Gaffney, D. L. Rock, and W. M. Nelson. 2002. Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. J. Am. Vet. Med. Assoc. 220:1636-1642.
10. Chinsangaram, J., M. Koster, and M. J. Grubman. 2001 Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75:5498-5503.
11. Chinsangaram, J., M. P. Moraes, M. Koster, and M. J. Grubman. 2003. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease. J. Virol. 77:1621-1625.
12. Chinsangaram, J., M. E. Piccone, and M. J. Grubman. 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
13. David, D., Y. Strain, H. Yadin, Z. Trainin, and Y. Becker. 1995. Foot and mouth disease virus replication in bovine skin Langerhans cells under in vitro conditions detected by RT-PCR. Virus Genes 10:5-13.
14. Devaney, M. A., V. N. Vakharia, R. E. Lloyd, E. Ehrenfeld, and M. J. Grubman. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62:4407-4409.
15. Diaz de Arce, H., K. Artursson, R. L'Haridon, A. Perers, C. La Bonnardiere, and G. V. Alm. 1992. A sensitive immunoassay for porcine interferon-α. Vet. Immunol. Immunopathol. 30:319-327.
16. Diebold, S. S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L. E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324-328.
17. Dunn, C. S., and A. I. Donaldson. 1997. Natural adaptation to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Vet. Rec. 141:174-175.
18. Ferguson, N. M., C. A. Donnelly, and R. M. Anderson. 2001. The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science 292:1155-1160.
19. Ferguson, N. M., C. A. Donnelly, and R. M. Anderson. 2001. Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain. Nature 413:542-548.
20. Gregg, D. A., D. H. Schlafer, and C. A. Mebus. 1995. African swine fever virus infection of skin-derived dendritic cells in vitro causes interference with subsequent foot-and-mouth disease virus infection. J. Vet. Diagn. Investig. 7:44-51.
21. Grosjean, I., C. Caux, C. Bella, I. Berger, F. Wild, J. Banchereau, and D. Kaiserlian. 1997. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 186:801-812.
22. 1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J. Gen. Virol. 81:1383-1391.
23. Kadowaki, N., S. Antonenko, J. Y. Lau, and Y. J. Liu. 2000. Natural interferon α/β-producing cells link innate and adaptive immunity. J. Exp. Med. 192:219-226.
24. Kadowaki, N., and Y. J. Liu. 2002. Natural type 1 interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol. 63:1126-1132.
25. Knowles, N. J., P. R. Davies, T. Henry, V. O'Donnell, J. M. Pacheco, and P. W. Mason. 2001. Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J. Virol. 75:1551-1556.
26. Knowles, N. J., A. R. Samuel, P. R. Davies, R. P. Kitching, and A. I. Donaldson. 2001. Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet. Rec. 148:258-259.
27. Le Bon, A., and D. F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14:432-436.
28. L'Haridon, R. M., P. Bourget, F. Lefevre, and C. La Bonnardiere. 1991. Production of an hybridoma library to recombinant porcine alpha I interferon: a very sensitive assay (ISBBA) allows the detection of a large number of clones. Hybridoma 10:35-47.
29. Livden, J. K., R. Nilsen, J. R. Bjerke, and R. Matre. 1989. In situ localization of interferons in psoriatic lesions. Arch. Dermatol. Res. 281:392-397.
30. Luft, T., K. C. Pang, E. Thomas, P. Hertzog, D. N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947-1953.
31. Mayr, G. A., J. Chinsangaram, and M. J. Grubman. 1999. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263:496-506.
32. McCarty, M. F., D. Bielenberg, C. Donawho, C. D. Bucana, and I. J. Fidler. 2002. Evidence for the causal role of endogenous interferon-α/ β in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms. Clin. Exp. Metastasis 19:609-615.
33. McCullough, K. C., and R. N. Butcher. 1991. Function of idiotypic networks in vivo: immunisation with idiotype-bearing (Id1) antibody induces further production of Id1 antibody. Immunol. Lett. 27:9-12.
34. Medina, M., E. Domingo, J. K. Brangwyn, and G. J. Belsham. 1993. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194:355-359.
35. Mehta, V. B., J. Hart, and M. D. Wewers. 2001. ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem. 276:3820-3826.
36. Montoya, M., G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D. F. Tough. 2002. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99:3263-3271.
37. Moraes, M. P., J. Chinsangaram, M. C. Brum, and M. J. Grubman. 2003. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268-279.
38. Moraes, M. P., G. A. Mayr, and M. J. Grubman. 2001. pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs. BioTechniques 31:1050, 1052, 1054-1056.
39. 3 as its receptor. J. Virol. 72:3587-3594.
40. O'Donnell, V. K., J. M. Pacheco, T. M. Henry, and P. W. Mason. 2001. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology 287:151-162.
41. Oleksiewicz, M. B., A. I. Donaldson, and S. Alexandersen. 2001. Development of a novel real-time RT-PCR assay for quantitation of foot-and-mouth disease virus in diverse porcine tissues. J. Virol. Methods 92:23-35.
42. Palucka, K., and J. Banchereau. 1999. Dendritic cells: a link between innate and adaptive immunity. J. Clin. Immunol. 19:12-25.
43. Piccone, M. E., E. Rieder, P. W. Mason, and M. J. Grubman. 1995. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69:5376-5382.
44. Piccone, M. E., M. Zellner, T. F. Kumosinski, P. W. Mason, and M. J. Grubman. 1995. Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J. Virol. 69:4950-4956.
45. Rambukkana, A., J. D. Bos, D. Irik, W. J. Menko, M. L. Kapsenberg, and P. K. Das. 1995. In situ behavior of human Langerhans cells in skin organ culture. Lab. Investig. 73:521-531.
46. Reid, S. M., N. P. Ferris, G. H. Hutchings, Z. Zhang, G. J. Belsham, and S. Alexandersen. 2002. Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J. Virol. Methods 105:67-80.
47. Rieder, E., T. Bunch, F. Brown, and P. W. Mason. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:5139-5145.
48. Roberts, L. O., R. A. Seamons, and G. J. Belsham. 1998. Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins. RNA 4:520-529.
49. Robson, K. J., J. R. Crowther, A. M. King, and F. Brown. 1979. Comparative biochemical and serological analysis of five isolates of a single serotype of foot-and-mouth disease virus. J. Gen. Virol. 45:579-590.
50. Rowden, G., S. Boudreau, and H. Higley. 1985. Langerhans cells and extraepidermal dendritic cells. An investigation in laboratory animals and man with immunomorphological methods. Scand. J. Immunol. 21:471-478.
51. Sa-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123.
52. Saiz, M., J. I. Nunez, M. A. Jimenez-Clavero, E. Baranowski, and F. Sobrino. 2002. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect. 4:1183-1192.
53. Samuel, A. R., E. J. Ouldridge, A. E. Arrowsmith, R. P. Kitching, and N. J. Knowles. 1990. Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981 to 1988. Vaccine 8:390-396.
54. Siders, W. M., J. C. Klimovitz, and S. B. Mizel. 1993. Characterization of the structural requirements and cell type specificity of IL-1 alpha and IL-1 beta secretion. J. Biol. Chem. 268:22170-22174.
55. Siders, W. M., and S. B. Mizel. 1995. Interleukin-1β secretion. A possible multistep process that is regulated in a cell type-specific manner. J. Biol. Chem. 270:16258-16264.
56. Splichal, I., M. Bonneau, and B. Charley. 1994, Ontogeny of interferon alpha secreting cells in the porcine fetal hematopoietic organs. Immunol. Lett. 43:203-208.
57. Stoitzner, P., K. Pfaller, H. Stossel, and N. Romani. 2002. A close-up view of migrating Langerhans cells in the skin. J. Investig. Dermatol. 118:117-125.
58. Stosel, H., F. Koch, and N. Romani. 1997. Maturation and migration of mutine dendritic cells in situ. Observations in a skin organ culture model. Adv. Exp. Med. Biol. 417:311-315.
59. Summerfield, A., L. Guzylack-Piriou, A. Schaub, C. P. Carrasco, V. Tache, B. Charley, and K. C. McCullough. 2003. Porcine peripheral blood dendritic cells and natural interferon-producing cells. Immunology 110:440-449.
60. Taki, S. 2002. Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice. Cytokine Growth Factor Rev. 13:379-391.
61. Tsai, C. P., C. H. Pan, M. Y. Liu, Y. L. Lin, C. M. Chen, T. S. Huang, I. C. Cheng, M. H. Jong, and P. C. Yang. 2000. Molecular epidemiological studies on foot-and-mouth disease type O Taiwan viruses from the 1997 epidemic. Vet. Microbiol. 74:207-216.
62. Weinlich, G., M. Heine, H. Stossel, M. Zanella, P. Stoitzner, U. Ortner, J. Smolle, F. Koch, N. T. Sepp, G. Schuler, and N. Romani. 1998. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J. Investig. Dermatol. 110:441-448.
63. Wu, Q., M. C. Brum, L. Caron, M. Koster, and M. J. Grubman. 2003. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J. Interferon Cytokine Res. 23:359-368.
64. Zinn, K., A. Keller, L. A. Whittemore, and T. Maniatis. 1988. 2-Aminopurine selectively inhibits the induction of β-interferon, c-fos, and c-myc gene expression. Science 240:210-213.